Literature DB >> 10706562

Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis.

C Hermenegildo1, P Monfort, V Felipo.   

Abstract

Ammonia is considered the main agent responsible for the neurological alterations in hepatic encephalopathy. It was suggested that ammonia toxicity is mediated by activation of N-methyl-D-aspartate (NMDA) receptors. The aim of this work was to assess, by in vivo brain microdialysis in freely moving rats, whether acute ammonia intoxication leads to activation of NMDA receptors in the cerebellum of the rat in vivo. We measured the effects of ammonia intoxication on the neuronal glutamate-nitric oxide-cyclic guanosine monophosphate (cGMP) pathway, by measuring the ammonia-induced increase of extracellular cGMP. Ammonia intoxication increases extracellular cGMP, and this increase is prevented by (5R,10S)-5-methyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imine hydrogen maleate (MK-801). There is a good correlation between the increase in cGMP and the seriousness of the neurological symptoms elicited by different doses of ammonia. Ammonia doses inducing coma did not affect extracellular glutamate, while doses leading to death increased it by 349%. The time courses of ammonia-induced increases in extracellular ammonia, cGMP, and glutamate indicate that NMDA receptor activation occurs before the increase in extracellular glutamate. Ammonia-induced increase in glutamate is prevented by MK-801. These results indicate that ammonia intoxication leads to activation of NMDA receptors in the animal in vivo, and that this activation is not caused by increased extracellular glutamate. The possible underlying mechanism is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706562     DOI: 10.1002/hep.510310322

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  65 in total

1.  Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis.

Authors:  Jan Albrecht
Journal:  J Mol Med (Berl)       Date:  2007-02-02       Impact factor: 4.599

Review 2.  Therapy of intracranial hypertension in patients with fulminant hepatic failure.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  The function of the glutamate-nitric oxide-cGMP pathway in brain in vivo and learning ability decrease in parallel in mature compared with young rats.

Authors:  Blanca Piedrafita; Omar Cauli; Carmina Montoliu; Vicente Felipo
Journal:  Learn Mem       Date:  2007-04-05       Impact factor: 2.460

4.  A zebrafish model of hyperammonemia.

Authors:  B Feldman; M Tuchman; L Caldovic
Journal:  Mol Genet Metab       Date:  2014-07-10       Impact factor: 4.797

5.  Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.

Authors:  G F Cittolin-Santos; A M de Assis; P A Guazzelli; L G Paniz; J S da Silva; M E Calcagnotto; G Hansel; K C Zenki; E Kalinine; M M Duarte; D O Souza
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

Review 6.  Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.

Authors:  Rafael Ochoa-Sanchez; Christopher F Rose
Journal:  J Clin Exp Hepatol       Date:  2018-08-18

7.  Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study.

Authors:  Selvaraju Subash; Perumal Subramanian
Journal:  Mol Cell Biochem       Date:  2009-02-24       Impact factor: 3.396

Review 8.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 9.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

10.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.